Bababeygy Simon R, Zoumalan Christopher I, Manche Edward E
Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA 94305, USA.
J Cataract Refract Surg. 2008 Jan;34(1):21-7. doi: 10.1016/j.jcrs.2007.08.032.
To evaluate the safety, efficacy, and clinical outcomes of wavefront-guided laser in situ keratomileusis (LASIK) surgery for the treatment of moderate to high myopia and compound myopic astigmatism.
Stanford University School of Medicine, Department of Ophthalmology, Stanford, California, USA.
This retrospective study included patients with moderate (-6.0 to -8.0 diopters [D]) and high (greater than -8.00) myopia treated with wavefront-guided LASIK using the WaveScan linked to the CustomVue system (AMO USA, Inc.). Eyes were analyzed preoperatively and 1, 3, and 12 months postoperatively.
The mean patient age was 38.4 years +/- 7.14 (SD). Eighty-nine eyes of 45 patients were evaluated at 3 months and 50 eyes of 25 patients at 12 months. No eye was retreated during the study. The mean manifest refraction spherical equivalent was -8.10 +/- 0.98 D (range -6.00 to -10.63 D) preoperatively and -0.33 +/- 0.55 D (range -1.625 to 1.375 D) 12 months postoperatively. Ninety percent of the eyes were within +/-1.00 D of the intended correction and 64.0%, within +/-0.50 D. For all eyes, the safety index was 1.00 and the efficacy index, 1.18.
The data support the safety and efficacy of correcting moderate to high myopia and compound myopic astigmatism using wavefront-guided LASIK.
评估波前引导准分子原位角膜磨镶术（LASIK）治疗中高度近视及复合性近视散光的安全性、有效性及临床效果。
美国加利福尼亚州斯坦福大学医学院眼科。
本回顾性研究纳入了使用与CustomVue系统（美国AMO公司）相连的WaveScan进行波前引导LASIK治疗的中高度近视（-6.0至-8.0屈光度[D]）和高度近视（大于-8.00 D）患者。于术前及术后1个月、3个月和12个月对眼睛进行分析。
患者平均年龄为38.4岁±7.14（标准差）。45例患者中的89只眼在术后3个月接受评估，25例患者中的50只眼在术后12个月接受评估。研究期间无眼接受再次手术。术前平均显验光球镜等效度为-8.10±0.98 D（范围为-6.00至-10.63 D），术后12个月为-0.33±0.55 D（范围为-1.625至1.375 D）。90%的眼屈光度数在预期矫正度数的±1.00 D范围内，64.0%在±0.50 D范围内。所有眼的安全指数为1.00，有效指数为1.18。
数据支持使用波前引导LASIK矫正中高度近视及复合性近视散光的安全性和有效性。
Zotero 插件